Major histocompatibility complex class II molecules function as a template for the processing of a partially processed insulin peptide into a T-cell epitope

Diabetes

Volumn 45, Issue 12, 1996, Pages 1711-1719

  Lang, Ying ^a   Forquet, Frederique ^a   Speck, Edwin ^a   Blunt, Janice ^b   Delovitch, Terry L ^a  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

^b INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; CATHEPSIN D; EPITOPE; INSULIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; T LYMPHOCYTE ANTIGEN;

ANIMAL CELL; ANTIGEN BINDING; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; DNA TEMPLATE; ETIOLOGY; GENETIC SUSCEPTIBILITY; INSULIN SYNTHESIS; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

EID: 0029962616     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.45.12.1711     Document Type: Article

References (56)

1. Engelhard VH: Structure of peptides associated with class I and class II MHC molecules. Annu Rev Immunol 12:181-207, 1994
2. Cresswell P: Assembly, transport, and function of MHC class II molecules. Annu Rev Immunol 12:259-293, 1994
3. Peters PJ, Neefjes JJ, Oorschot V, Ploegh HL, Geuze HJ: Segregation of class II molecules from MHC class II molecules in the Golgi complex for transport to lysosomal compartments. Nature 349:669-676, 1991
4. Takahashi H, Cease KB, Berzofsky JA: Identification of proteases that process distinct epitopes on the same protein. J Immunol 142:2221-2229, 1989
5. Van Noort JM, Boon J, Van der Drift ACM, Wagenaar JPA, Boots AMH, Boog CJP: Antigen processing by endosomal proteases determines which sites of sperm-whale myoglobin are eventually recognized by T-cells. Eur J Immunol 21:1989-1996, 1991
6. Bennett K, Levine T, Ellis JS, Peansky R, Samloff MI, Kay J, Chain BM: Antigen processing for presentation by class II major histocompatibility complex requires cleavage by cathepsin E. Eur J Immunol 22:1519-1524, 1992
7. Sadegh-Nasseri S, Germain RN: A role for peptide in determining MHC class II structure. Nature 353:167-170, 1991
8. Germain RN, Hendrix LR: MHC class II structure, occupancy and surface expression determined by post-endoplasmic reticulum antigen binding. Nature 353:134-139, 1991
9. Roy S, Scherer T, Briner TJ, Smith AJ, Gefter ML: Murine MHC polymorphism and T-cell specificities. Science 244:572-575, 1989
10. Gammon G, Shastri N, Cogswell J, Wilbur S, Sadegh-Nasseri S, Krzych U, Miller A, Sercarz E: The choice of epitopes utilized on a protein antigen depends on multiple factors distant from as well as at the determinant site. Immunol Rev 98:53-73, 1987
11. Berzofsky JA, Brett SJ, Streicher HZ, Takahashi H: Antigen processing for presentation to T lymphocytes: function, mechanism, and implications for the T-cell repertoire. Immunol Rev 106:5-31, 1988
12. Rudensky AY, Preston-Hurlburt P, Hong SC, Barlow A, Janeway CA: Sequence analysis of peptides bound to MHC class II molecules. Nature 353:622-627, 1991
13. Sercarz EE, Lehmann PV, Ametani A, Benichou G, Miller A, Moudgil K: Dominance and crypticity of T-cell antigenic determinants. Annu Rev Immunol 11:729-766, 1993
14. Donermeyer DL, Allen PM: Binding to la protects an immunogenic peptide from proteolytic degradation. J Immunol 142:1063-1068, 1989
15. Madden DR: The three-dimensional structure of peptide-MHC complexes. Annu Rev Immunol 13:587-622, 1995
16. Mouritsen S, Meldal M, Werdelin O, Hansen AS, Buus S: MHC molecules protect T-cell epitopes against proteolytic destruction. J Immunol 49:1987-1993, 1992
17. Ojcius DM, Langlade-Demoyen P, Gachelin G, Kourilsky P: Role for MHC class I molecules in selecting and protecting high affinity peptides in the presence of proteases. J Immunol 152:2798-2810, 1994
18. Falk K, Rammensee HG: Cellular peptide composition governed by major histocompatibility complex class I molecules. Nature 348:248-251, 1990
19. Del Val M, Schlicht HJ, Ruppert T, Reddehase MJ, Koszinowski UH: Efficient processing of an antigenic sequence for presentation by MHC class 1 molecules depends on its neighboring residues in the protein. Cell 66:1145-1153, 1991
20. Zhang ZJ, Davidson L, Eisenbarth G, Weiner HL: Suppression of diabetes in NOD by oral administration of porcine insulin. Proc Natl Acad Sci USA 88:10252-10256, 1991
21. + T cells that suppress adoptive transfer of diabetes. J Autoimmun 7:655-663, 1994
22. Muir A, Peck A, Clare-Salzer M, Song YH, Corenelius J, Luchetta R, Krischer J, Maclaren N: Insulin immunization of NOD mice induces a protective insulitis characterized by diminished intraislet interferon-gamma transcription. J Clin Invest 95:628-634, 1995
23. Naquet P, Ellis J, Singh B, Hodges RS, Delovitch TL: Processing and presentation of insulin. I. Analysis of immunogenic peptides and processing requirements for insulin A loop-specific T-cells. J Immunol 139:3955-3963, 1987
24. d. Science 256:1817-1820, 1992
25. Kappler JW, Skidmore B, White J, Marrack P: Antigen-inducible, H-2 restricted, interleukin-2 producing T-cell hybridomas: lack of independent antigen and H-2 recognition. J Exp Med 153:1198-1214, 1981
26. Ozato K, Mayer N, Sachs DH: Hybridoma cell lines secreting monoclonal antibodies to mouse H-2 and la antigens. J Immunol 124:533-640, 1980
27. Blum JS, Diaz R, Diment S, Fiani M, Mayorga L, Rodman JS, Stahl PD: Proteolytic processing in endosomal vesicles. Cold Spring Harbor Symp Quant Biol 54:287-292, 1989
28. Shimonkevitz R, Kappler J, Marrack P, Grey H: Antigen recognition by H- 2 restricted T-cells. I. Cell-free antigen processing. J Exp Med 158:303-316, 1983
29. Glimcher LH, Schroer JA, Chan C, Shevach EH: Fine specificity of cloned insulin-specific T-cell hybridomas: evidence supporting a role for tertiary conformation. J Immunol 131:2868-2874, 1983
30. Hunter W, Greenwood F: Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature 194:495-498, 1962
31. Delovitch TL, Semple JW, Bernard NF, Ellis J, Champagne P, Phillips ML: Pathways of processing of insulin by antigen-presenting cells. Immunol Rev 106:195-222, 1988
32. Lin J, Berzofsky JA, Delovitch TL: Ultrastructural study of internalization and recycling of antigen by antigen presenting cells. J Mol Cell Immunol 3:321-345, 1988
33. Semple JW, Ellis J, Delovitch TL: Processing and presentation of insulin. II. Evidence for intracellular, plasma membrane-associated and extracellular degradation of human insulin by antigen-presenting B-cells. J Immunol 142:4184-4193, 1989
34. Jensen PE: Enhanced binding of peptide antigen to purified class II major histocompatibility proteins at acidic pH., J Exp Med 174:1111-1120, 1991
35. Glimcher LH, McKean DJ, Choi E, Seidman JG: Complex regulation of class II gene expression: analysis with class II mutant cell lines. J Immunol 135:3542-3550, 1985
36. Braunstein NS, Germain NR, Loney K, Berkowitz N: Structurally interde pendent and independent regions of allelic polymorphism in class II MHC molecules. J Immunol 145:1635-1645, 1990
37. d. Proc Natl Acad Sci USA 88:4661-4665, 1991
38. Jensen PE: Long-lived complexes between peptide and class II major histocompatibility complex are formed at low pH with no requirement for pH neutralization. J Exp Med 176:793-798, 1992
39. Lee JM, Watts TH: On the dissociation and reassociation of MHC class II-foreign peptide complexes: evidence that brief transit through an acidic compartment is not sufficient for binding site regeneration. J Immunol 144:1829-1834, 1990
40. Harding CV, Roof RW, Unanue ER: Turnover of Ia-peptide complex is facilitated in viable antigen-presenting cells: biosynthetic turnover of Ia vs peptide exchange. Proc Natl Acad Sci USA 86:4230-4234, 1989
41. Adorini L, Appella E, Doria G, Cardineaux F, Nagy Z: Competition for antigen presentation in living cells involves exchange of peptides bound by class II MHC molecules. Nature 342:800-803, 1989
42. Harding CV, Collins DS, Slot JV, Geuze HL, Unanue ER: Liposome-encapsulated antigens are processed in lysosomes, recycled, and presented to T-cells. Cell 64:393-401, 1991
43. Diment S: Different roles for thiol and aspartyl proteases in antigen presentation of ovalbumin. J Immunol 145:417-422, 1990
44. van Noort JM, van der Drift ACM: The selectivity of cathepsin D suggests an involvement of the enzyme in the generation of T-cell epitopes. J Biol Chem 264:14159-14164, 1989
45. Delovitch TL, Lazarus AH, Phillips ML, Semple JW: Antigen binding and processing by B-cell antigen-presenting cells: influence of T- and B-cell activation. Cold Spring Harbor Symp Quant Biol 54:333-343, 1989
46. Semple JW, Lang Y, Speck E, Delovitch TL: Processing and presentation of insulin. III. Insulin degrading enzyme: a neutral metallooendoproteinase that is non-homologous to classical endoproteinases mediates the processing of insulin epitopes for T helper cells. Int Immunol 4:1161-1167, 1992
47. Jensen PE: Reduction of disulfide bonds during antigen processing: evidence from a thiol-dependent insulin determinant. J Exp Med 1174:1121-1130, 1991
48. Hampl J, Gradehandt G, Kalbacher H, Rude E: In vitro processing of insulin for recognition by murine T-cells results in the generation of A chains with free CysSH. J Immunol 148:2664-2671, 1992
49. Gainey D, Short S, McCoy KL: Intracellular location of cysteine transport activity correlates with productive processing of antigen disulfide. J Cell Physiol 168:248-254, 1996
50. Harding C, Roof RW, Unanue ER: Turnover of Ia-peptide complexes is facilitated in viable antigen presenting cells: biosynthetic vs peptide exchange. Proc Natl Acad Sci USA 86:4230-4234, 1989
51. Reid PR, Watts C: Cycling of MHC class II glycoproteins through a primaquine-sensitive intracellular compartment. Nature 346:655-657, 1990
52. Streicher HZ, Berkhower IJ, Busch M, Gurd FRN, Berzofsky JA: Antigen conformation determines processing requirements for T-cell activation. Proc Natl Acad Sci USA 81:6831-6835, 1984
53. Lee P, Matsueda GR, Allen PM: T-cell recognition of fibrinogen: a determinant on the Act chain does not require processing. J Immunol 140:1063-1068, 1988
54. Sette A, Adorini L, Colon SM, Buus S, Grey HM: Capacity of intact proteins to bind to MHC molecules. J Immunol 143:1265-1267, 1989
55. Kaufman DL, Clare-Salzer M, Tian J, Fforsthuber T, Ting GSP, Robinson P, Atkinson MA, Sercarz EE, Tobin AJ, Lehmann PV: Spontaneous loss of T cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature 366:69-72, 1993
56. Tisch R, Yang XD, Singer SM, Liblau RS, Fugger L, McDevitt HO: Immune response to glutamic acid decarboxylase correlates with insulitis in nonobese diabetic mice. Nature 366:72-75, 1993